Status:
COMPLETED
Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy
Lead Sponsor:
Pfizer
Collaborating Sponsors:
Mclean Hospital
Conditions:
Fungal Infection
Eligibility:
MALE
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine the amount of voriconazole in the brain by fluorine-magnetic resonance spectroscopy (MRS) and to compare brain levels to plasma levels.
Eligibility Criteria
Inclusion
- Healthy male volunteers 18-55 years of age
Exclusion
- Subjects with any condition affecting drug absorption
- Subjects with a positive urine drug screen
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2005
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00136968
Start Date
April 1 2005
End Date
May 1 2005
Last Update
March 12 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.